V2X, Inc. — Form 10-Q Summary
Reporting period: Quarter ended September 30, 2022; nine-month comparisons are against the period ended October 1, 2021. Vectrus completed its merger with Vertex on July 5, 2022, and Vertex results are included only from that date. Accordingly, reported year-over-year comparisons are not fully comparable.
Business context and financial results
V2X provides mission support and related services, primarily to U.S. government and Department of Defense customers. It reports as one operating segment. The merger expanded the business and materially changed its revenue mix and capital structure.
| Metric | Q3 2022 | Q3 2021 | Nine months 2022 | Nine months 2021 |
|---|---|---|---|---|
| Revenue | $958.2 million | $459.4 million | $1,912.7 million | $1,364.3 million |
| Operating income | $4.5 million | $12.9 million | $24.7 million | $52.0 million |
| Operating margin | 0.5% | 2.8% | 1.3% | 3.8% |
| Net income (loss) | $(17.0) million | $10.3 million | $(3.7) million | $38.2 million |
| Diluted EPS | $(0.56) | $0.87 | $(0.21) | $3.23 |
| Net interest expense | $27.3 million | $2.0 million | $30.9 million | $6.1 million |
Q3 revenue grew 108.6%, including $451.6 million from Vertex and additional growth in legacy programs. Nine-month revenue rose 40.2%. Cost of revenue was 89.9% of revenue in Q3 versus 91.2% a year earlier; SG&A rose substantially, to $92.6 million in Q3 from $27.6 million. Management attributed weaker operating income primarily to merger-related and integration costs. For the nine months, cost of revenue was 90.6% of revenue, approximately flat with the prior-year 90.5%.
Cash flow, debt and liquidity
- Nine-month operating cash flow was $99.8 million, compared with $53.4 million in 2021. Capital expenditures were $8.2 million. Investing cash flow was $186.2 million, substantially reflecting cash acquired in the merger; financing cash flow was negative $165.3 million.
- At September 30, cash and cash equivalents were $144.1 million, plus $3.3 million restricted cash. Approximately $30.8 million of unrestricted cash was held by foreign subsidiaries.
- Balance-sheet short- and long-term debt, net, totaled approximately $1.299 billion. Scheduled principal on the first- and second-lien facilities totaled $1.365 billion; the $200 million ABL facility had no borrowings, $14 million of letters of credit outstanding, and $184.9 million of available borrowing capacity. The filing reports covenant compliance.
- First-lien and second-lien effective interest rates were 7.63% and 11.28%, respectively. Management estimates each one-percentage-point change in rates on these variable-rate facilities would change annual cash interest expense by $13.6 million.
- Receivables were $690.9 million, including $490.1 million of unbilled receivables/contract assets. Days sales outstanding was 65 days, down from 75 at year-end 2021.
Outlook, commentary and risks
- No specific revenue or earnings guidance is provided. Management said cash, operating cash flows and ABL availability should fund anticipated operating costs, capital expenditures and current debt repayments for at least 12 months.
- Total backlog was $12.7 billion, up from $5.0 billion at December 2021, including $2.9 billion funded and $9.8 billion unfunded. Remaining performance obligations were $3.362 billion; the company expects to recognize approximately 26% as revenue in the remainder of 2022 and 74% during 2023. Options and government funding remain subject to customer decisions.
- A continuing resolution funded U.S. government activity through December 16, 2022; management said key contracts continued to be funded and supported. Final FY2023 appropriations were not yet enacted.
- Risks include government budget and contract changes or termination, audits and cost disallowances, contract protests, workforce and supply-chain constraints, inflation, rising interest rates, and execution and integration of the merger. Fixed-price and time-and-materials work heightens exposure to cost overruns; about 40% of U.S. government contract revenue following the merger was from these contract types.
- Legal and government-contract claims accruals were $39.6 million, versus $9.6 million at year-end. Management did not expect asserted or unasserted matters to have a material adverse effect, while noting outcomes cannot be predicted with certainty.
- The merger’s purchase-price allocation remains preliminary and could be materially adjusted. It recorded $1.216 billion of goodwill and $522 million of customer-related intangible assets. The company reported $28.2 million of acquisition-related costs for Q3 and $41.3 million for the nine months; MD&A separately cites $44.9 million and $59.9 million of M&A and integration costs, respectively.
Important facts for investors to verify
- How much of backlog converts to funded, profitable revenue, and how contract options and government appropriations affect that conversion.
- Whether merger integration produces durable margin improvement and how recurring versus one-time merger and integration costs are classified.
- Debt repayment capacity, exposure to floating interest rates, and compliance with credit-facility covenants as rates and cash flows change.
- The final acquisition accounting, including valuation adjustments, goodwill and intangible-asset amortization.
- Exposure to fixed-price contract overruns, inflation, government audits, claims and the $39.6 million accrued contingency balance.
- The filing states disclosure controls were effective, but Vertex’s internal controls were excluded from the assessment while integration and evaluation continued. Verify subsequent integration and control updates.